Dean Capital Investments Management LLC Acquires New Stake in Fresenius Medical Care AG & Co. (FMS)

Dean Capital Investments Management LLC bought a new stake in shares of Fresenius Medical Care AG & Co. (NYSE:FMS) during the 4th quarter, according to the company in its most recent disclosure with the SEC. The fund bought 4,938 shares of the company’s stock, valued at approximately $259,000.

A number of other large investors have also added to or reduced their stakes in FMS. UBS Asset Management Americas Inc. lifted its holdings in shares of Fresenius Medical Care AG & Co. by 3.6% during the 2nd quarter. UBS Asset Management Americas Inc. now owns 2,357 shares of the company’s stock valued at $114,000 after buying an additional 81 shares during the last quarter. Stifel Financial Corp acquired a new stake in shares of Fresenius Medical Care AG & Co. during the 2nd quarter valued at about $225,000. Raymond James Financial Services Advisors Inc. acquired a new stake in shares of Fresenius Medical Care AG & Co. during the 3rd quarter valued at about $239,000. Pacer Advisors Inc. lifted its holdings in shares of Fresenius Medical Care AG & Co. by 37.6% during the 3rd quarter. Pacer Advisors Inc. now owns 5,105 shares of the company’s stock valued at $250,000 after buying an additional 1,394 shares during the last quarter. Finally, Toronto Dominion Bank acquired a new stake in shares of Fresenius Medical Care AG & Co. during the 3rd quarter valued at about $277,000. 2.57% of the stock is currently owned by institutional investors.

Several equities research analysts have recently issued reports on FMS shares. UBS Group upgraded Fresenius Medical Care AG & Co. from a “sell” rating to a “neutral” rating in a report on Thursday, January 4th. Zacks Investment Research lowered Fresenius Medical Care AG & Co. from a “buy” rating to a “sell” rating in a report on Wednesday, October 25th. DZ Bank restated a “buy” rating on shares of Fresenius Medical Care AG & Co. in a report on Monday, December 18th. Nord/LB restated a “buy” rating on shares of Fresenius Medical Care AG & Co. in a report on Wednesday, December 27th. Finally, Morgan Stanley lowered Fresenius Medical Care AG & Co. from an “overweight” rating to an “equal weight” rating in a report on Monday, December 11th. Six equities research analysts have rated the stock with a hold rating and four have given a buy rating to the company’s stock. The stock currently has an average rating of “Hold” and a consensus target price of $56.00.

Fresenius Medical Care AG & Co. (NYSE:FMS) opened at $52.05 on Monday. The company has a market capitalization of $31,901.65, a P/E ratio of 23.34, a PEG ratio of 1.98 and a beta of 0.52. The company has a current ratio of 1.22, a quick ratio of 0.98 and a debt-to-equity ratio of 0.55. Fresenius Medical Care AG & Co. has a 1-year low of $40.21 and a 1-year high of $57.94.

COPYRIGHT VIOLATION WARNING: “Dean Capital Investments Management LLC Acquires New Stake in Fresenius Medical Care AG & Co. (FMS)” was originally posted by The Lincolnian Online and is owned by of The Lincolnian Online. If you are reading this piece of content on another domain, it was illegally stolen and reposted in violation of international copyright & trademark law. The original version of this piece of content can be accessed at https://www.thelincolnianonline.com/2018/02/12/dean-capital-investments-management-llc-purchases-shares-of-4938-fresenius-medical-care-ag-co-fms-updated.html.

Fresenius Medical Care AG & Co. Profile

Fresenius Medical Care AG & Co KGaA is a kidney dialysis company. The Company provides dialysis care and related services to persons suffering from end-stage renal disease (ESRD), as well as other healthcare services. The Company’s segments include North America Segment, the Europe, Middle East and Africa (EMEA) Segment, the Asia-Pacific Segment and the Latin America Segment.

Institutional Ownership by Quarter for Fresenius Medical Care AG & Co. (NYSE:FMS)

Receive News & Ratings for Fresenius Medical Care AG & Co. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Fresenius Medical Care AG & Co. and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply